News
ALURW
0.019
0.00%
0.000
Allurion Technologies treats first commercial patients in the U.S.
TipRanks · 4d ago
Weekly Report: what happened at ALUR last week (0413-0417)?
Weekly Report · 5d ago
Weekly Report: what happened at ALUR last week (0406-0410)?
Weekly Report · 04/13 10:22
Weekly Report: what happened at ALUR last week (0330-0403)?
Weekly Report · 04/06 10:22
Weekly Report: what happened at ALUR last week (0323-0327)?
Weekly Report · 03/30 10:22
Weekly Report: what happened at ALUR last week (0316-0320)?
Weekly Report · 03/23 10:19
Tracking Saudi Sovereign Wealth Fund's 13F Portfolio - Q4 2025 Update
Seeking Alpha · 03/17 01:01
Weekly Report: what happened at ALUR last week (0309-0313)?
Weekly Report · 03/16 10:18
Allurion Faces NYSE Delisting, Shifts Trading to OTC
TipRanks · 03/12 21:34
Allurion Technologies appeals NYSE decision to initiate delisting proceedings
TipRanks · 03/12 20:26
Weekly Report: what happened at ALUR last week (0302-0306)?
Weekly Report · 03/09 10:18
8 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 03/03 12:05
Allurion Technologies Appeals NYSE Delisting, Plans Compliance Strategy
TipRanks · 03/02 16:02
Allurion Technologies to appeal NYSE notice of delisting
TipRanks · 03/02 14:25
Allurion Technologies Plans To Appeal NYSE's Delisting Decision
Benzinga · 03/02 14:07
Weekly Report: what happened at ALUR last week (0223-0227)?
Weekly Report · 03/02 10:18
Weekly Buzz: MGNX's LINNET Trial On Hold; ETON, ALUR Get FDA Nod; GILD Snaps Up ACLX
NASDAQ · 02/27 14:17
What's Going On With Allurion Stock On Wednesday?
Benzinga · 02/25 15:39
Allurion Technologies Amends Warrants to Bolster Liquidity
TipRanks · 02/25 14:00
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session
Benzinga · 02/24 21:06
More
Webull provides a variety of real-time ALURW stock news. You can receive the latest news about ALLURION TECHNOLOGIES INC through multiple platforms. This information may help you make smarter investment decisions.
About ALURW
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.